首页> 外文期刊>The pharmaceutical journal >CHRE concerned about representation on regulatory review
【24h】

CHRE concerned about representation on regulatory review

机译:CHRE担心监管审查的代表性

获取原文
获取原文并翻译 | 示例
           

摘要

Concern over the absence of representatives of many regulatory bodies from a Department of Health review group has been expressed within the Council for Healthcare Regulatory Excellence.But the council left it to individual regulators to take up the matter with the DoH.Only two of the six health regulators responsible for 19 professions under review - the Nursing and Midwifery Council and the Health Professions Council - are represented on the group.Instead,most,including the Royal Pharmaceutical Society,are restricted to participation in a reference group conference,which will meet for the first time in July.No details of any other reference group activities are available.
机译:卫生保健卓越监管委员会对卫生部审查小组缺少许多监管机构的代表表示担忧,但该理事会将其留给各个监管机构与卫生部讨论此事。六个国家中只有两个负责19个受审专业的健康监管机构-护理和助产理事会和健康专业理事会-参加了该小组。相反,包括皇家制药协会在内的大多数机构仅限参加参考小组会议,该会议将召开7月的第一次。没有其他参考小组活动的详细信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号